嗯,b1 臨床美德2國都早做過了,也早就被淘汰了。
回答: 這個發表的正是BNT162b1,複星跟BNT162b2根本就不沾邊,複星要是之後做了什麽b2的臨床試驗,也屬於毫無必要的強行掛靠
由 Circuseer
於 2021-04-25 13:18:52
WENXUECITY.COM does not represent or guarantee the truthfulness, accuracy, or reliability of any of communications posted by other users.
Copyright ©1998-2024 wenxuecity.com All rights reserved. Privacy Statement & Terms of Use & User Privacy Protection Policy